Wednesday January 24th, 2018

Fourth call of the PhD4MD biomedical research training programme for medical doctors

The Centre for Genomic Regulation (CRG), the August Pi i Sunyer Biomedical Research Institute  (IDIBAPS), the Institute for Research in Biomedicine (IRB Barcelona), and the Vall d’Hebron Research Institute (VHIR) have launched the fourth call of the training programme “PhD for Medical Doctors – PhD4MD”. Read the rest of this entry »

Tuesday January 23rd, 2018

Researchers identify a protein that keeps metastatic breast cancer cells dormant

The time needed for breast cancer metastases (secondary lesions caused by cells that have escaped from the original tumour) to develop varies between patients, and little is known about the mechanisms that govern latency (the dormant state of cells that have already spread through the body). A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light on the molecular basis underlying how the expression of certain genes facilitates the spread of metastatic lesions. Dr. Aleix Prat, Head of the Clinical Oncology Department at Hospital Clínic and of the Translational genomics and targeted therapeutics in solid tumors research team at IDIBAPS, has participated in this study. Read the rest of this entry »

Friday December 29th, 2017

El Dr. Ricard Cervera, Presidente de Honor del 5th Latin American Congress of Autoimmunity

Los pasados 26 al 29 de noviembre tuvo lugar en Cancún (Mèxic) el 5th Latin American Congress of Autoimmunity, el encuentro más importante de los especialistas de los laboratorios de inmunidad y de los clínicos de las principales especializades relacionadas con las enfermedades autoinmunes. Este año, el congreso ha contado con el Dr. Ricard Cervera, Jefe del Servicio de Enfermedades Autoinmunes (ICMiD), como Presidente de Honor, junto con el Dr. Yehuda Schoenfeld de Israel.

Read the rest of this entry »

No Comments
Saturday December 16th, 2017

A new combination of antibiotics allows treating 60% of hospital-acquired pneumonia

A study published in the journal The Lancet Infectious Diseases shows the ability of a new antibiotic (ceftazimida-avibactam) to treat hospital-acquired pneumonia, including ventilation-associated pneumonia. It has similar efficacy to one of the most used type of antibiotics in the treatment of this infection, carbapenems, but has the advantage of overcoming problems derived from its administration, such as the resistance of certain bacteria. Dr. Antoni Torres, Head of the Respiratory Intensive Surveillance Unit (UVIR) of the Hospital Clínic and head of the IDIBAPS team on Applied research in infectious respiratory diseases, critically ill patients and lung cancer, is the principal investigator of the study and first author of the article. Read the rest of this entry »

No Comments


Posted in:

Monday December 11th, 2017

Moderate exercise training improves some of the Marfan syndrome symptoms in mice

Regular physical activity is a common therapy for people with cardiovascular problems, but not recommended to those with Marfan syndrome, a rare disease of the connective tissue, but mainly affecting the cardiovascular system. A study conducted jointly by the University of Barcelona and the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) has analysed for the first time this medical recommendation analysing the impact of exercise in the development of the disease in mice. The results, published in the scientific journal Journal of the American Heart Association, show that moderate exercise reduces the progression of the aortic aneurysm, one of the most severe symptoms of the disease which can cause arteries to break. Read the rest of this entry »

No Comments


Posted in:

Thursday November 30th, 2017

IDIBAPS hosts the annual meeting of the European AIDS Vaccine Initiative (EAVI2020)

At the beginning of November, scientists from 22 institutions in Europe, Australia, Canada and the United States, which are part of the European AIDS Vaccine Initiative 2020 (EAVI2020), met in Barcelona to analyze the latest advances in the development of an effective vaccine against HIV within the framework of the European Research and Development Program Horizon 2020. The three Spanish centers participating in this consortium are the IDIBAPS, organizer of the meeting, the IrsiCaixa AIDS Research Institute and the Institute of Health Carlos III. In the context of the meeting a photo exhibition entitled “The development of an HIV vaccine in photos” was presented, with the aim of sharing the scientific advances at the community level. This exhibition can be visited at the Hospital Clínic of Barcelona until February 2018. Read the rest of this entry »

No Comments
Page 1 of 10412345...Last »